J. Robert And NotBiodisponibilité
List of bibliographic references
Number of relevant bibliographic references: 8.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001523 | A. Trimeche [France] ; M. N. Bera [France] ; J.-P. Cromieres [France] ; J. Robert [France] ; N. Vanhaecke [France] | Trapping of a supersonic beam in a traveling magnetic wave |
| 003E93 | J. Robert [France] ; V. Simonet [France] ; B. Canals [France] ; R. Ballou [France] ; P. Bordet [France] ; I. Gelard [France] ; A. Ibanez [France] ; P. Lejay [France] ; J. Ollivier [France] ; A. Stunault [France] | Magnetic excitations in a new anisotropic kagome antiferromagnet |
| 005D48 | H. M. Dodds [Australie] ; S. J. Clarke [Australie] ; M. Findlay [Nouvelle-Zélande] ; J. F. Bishop [Australie] ; J. Robert [France] ; L. P. Rivory [Australie] | Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance |
| 006239 | H. M. Dodds [Australie] ; J. Robert [France] ; L. P. Rivory [Australie] | The detection of photodegradation products of irinotecan (CPT-11, Campto®, Camptosar®), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry |
| 006343 | M.-C. Haaz [France] ; L. Rivory [Australie] ; C. Riche [France] ; L. Vernillet [France] ; J. Robert [France] | Metabolism of irinotecan (CPT-11) by human hepatic microsomes : Participation of cytochrome P-450 3A and drug interactions |
| 006488 | M.-C. Haaz [France] ; C. Riche [France] ; L. P. Rivory [Australie] ; J. Robert [France] | Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1 -piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes |
| 006935 | L. P. Rivory [Australie, France] ; J.-F. Riou [États-Unis] ; M.-C. Haaz [France] ; S. Sable [États-Unis] ; M. Vuilhorgne [États-Unis] ; A. Commercon [États-Unis] ; S. M. Pond [Australie] ; J. Robert [France] | Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients |
| 006965 | L. P. Rivory [Australie] ; M. R. Bowles [Australie] ; J. Robert [France] ; S. M. Pond [Australie] | Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase |
| This area was generated with Dilib version V0.6.33. |  |